Sefunda AG

Sefunda is on a mission to make rapid PCR testing an accessible standard for everybody. To date most infectious diseases are treated empirically, meaning a broad-spectrum antibiotic or a combination regimen is prescribed covering multiple possible pathogens. The gold standard for evidence-based treatment is elaborate lab testing including molecular testing and microbiological culture, which is costly and time consuming. Sefunda takes up the banner to democratize patient tailored medicine by filling a blank between cost prohibitive lab workup and empiric treatment. We are developing a fully integrated rapid PCR platform delivering just the right amount of actionable information on the spot.